AllSquare Wealth Management’s GSK GSK Stock Holding History

AllSquare Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$3.45K	Hold	80	–	–	﹤0.01%	445
2025 Q2	$3.07K	Hold	80	–	–	﹤0.01%	451
2025 Q1	$3.1K	Hold	80	–	–	﹤0.01%	453
2024 Q4	$2.71K	Hold	80	–	–	﹤0.01%	456
2024 Q3	$3.27K	Hold	80	–	–	﹤0.01%	450
2024 Q2	$3.08K	Sell	80 -1,900	-96%	-$79.9K	﹤0.01%	448
2024 Q1	$84.9K	Hold	1,980	–	–	0.05%	168
2023 Q4	$73.4K	Sell	1,980 -500	-20%	-$17.9K	0.05%	174
2023 Q3	$89.9K	Hold	2,480	–	–	0.06%	146
2023 Q2	$84K	Sell	2,480 -80	-3%	-$2.87K	0.05%	158
2023 Q1	$91.1K	Hold	2,560	–	–	0.06%	149
2022 Q4	$90K	Hold	2,560	–	–	0.06%	145
2022 Q3	$75K	Hold	2,560	–	–	0.05%	149
2022 Q2	$139K	Hold	2,560	–	–	0.09%	108
2022 Q1	$139K	Hold	2,560	–	–	0.08%	119
2021 Q4	$141K	Hold	2,560	–	–	0.08%	117
2021 Q3	$122K	Hold	2,560	–	–	0.07%	123
2021 Q2	$127K	Hold	2,560	–	–	0.07%	131
2021 Q1	$114K	Sell	2,560 -1,840	-42%	-$83.5K	0.07%	134
2020 Q4	$202K	Sell	4,400 -617	-12%	-$28.3K	0.13%	86
2020 Q3	$236K	Hold	5,017	–	–	0.17%	68
2020 Q2	$256K	Hold	5,017	–	–	0.19%	63
2020 Q1	$238K	Sell	5,017 -160	-3%	-$8.54K	0.21%	57
2019 Q4	$304K	Sell	5,177 -160	-3%	-$8.9K	0.21%	65
2019 Q3	$285K	Hold	5,337	–	–	0.21%	63
2019 Q2	$267K	Hold	5,337	–	–	0.2%	68
2019 Q1	$279K	Hold	5,337	–	–	0.21%	62
2018 Q4	$255K	Hold	5,337	–	–	0.21%	60
2018 Q3	$268K	Buy	5,337 +407	+8%	+$20.7K	0.2%	63
2018 Q2	$248K	Buy	4,930 +210	+4%	+$10.6K	0.19%	64
2018 Q1	$231K	Hold	4,720	–	–	0.18%	60
2017 Q4	$209K	Sell	4,720 -800	-14%	-$37K	0.16%	69
2017 Q3	$280K	Buy	+5,520	New	+$280K	0.23%	53
2017 Q2	–	Sell	-5,120	Closed	-$270K	–	252
2017 Q1	$270K	Hold	5,120	–	–	0.24%	57
2016 Q4	$246K	Sell	5,120 -480	-9%	-$23.7K	0.23%	57
2016 Q3	$302K	Hold	5,600	–	–	0.29%	42
2016 Q2	$303K	Sell	5,600 -640	-10%	-$33.7K	0.3%	37
2016 Q1	$316K	Buy	6,240 +2,640	+73%	+$131K	0.31%	39
2015 Q4	$182K	Buy	3,600 +400	+13%	+$20.4K	0.18%	53
2015 Q3	$154K	Hold	3,200	–	–	0.16%	55
2015 Q2	$167K	Hold	3,200	–	–	0.16%	58
2015 Q1	$185K	Buy	3,200 +3,120	+3,900%	+$179K	0.18%	54
2014 Q4	$4K	Buy	+80	New	+$4.48K	﹤0.01%	278

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AllSquare Wealth Management's GSK Position: Q3 2025 in Review

AllSquare Wealth Management held its GSK (GSK) position steady in Q3 2025 at 80 shares worth $3.45K. The position accounts for ﹤0.01% of the portfolio, ranked #445.

AllSquare Wealth Management first reported a position in GSK in Q4 2014 and has held it in 43 quarters since. The position peaked at $316K in Q1 2016. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

AllSquare Wealth Management held 80 shares of GSK worth $3.45K as of Q3 2025.
AllSquare Wealth Management left its GSK share count unchanged in Q3 2025.
GSK made up ﹤0.01% of AllSquare Wealth Management's portfolio in Q3 2025, its #445 holding.
AllSquare Wealth Management first reported a position in GSK in Q4 2014 and has held it in 43 quarters since.
AllSquare Wealth Management's GSK position peaked at $316K in Q1 2016.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.